RNA Sequencing Services
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Points of contact
-
- NCTR Acquisition Liaison nctracquisitions@fda.hhs.gov
- tbd@fda.hhs.gov (301) 827-3742
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is forecasting a new requirement for RNA Sequencing Services to support PHCE protocol initiatives. This procurement falls under Research and Development in Biotechnology (NAICS 541714) and does not utilize any set-aside contracting mechanisms. The solicitation is expected to be released on May 1, 2026, with an estimated award date of July 1, 2026.
The estimated contract award value ranges from $25,000 to $250,000. Interested contractors should direct inquiries to the Food and Drug Administration's acquisition team, with primary contacts including a general FDA mailbox at tbd@fda.hhs.gov and the Acquisition Liaison at nctracquisitions@fda.hhs.gov. Additional details regarding specific performance requirements, deliverables, and timeline expectations will be clarified upon solicitation release.
Forecast text
Sequencing services request to support PHCE protocol
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast